Medicare Enrolled
Dr. Vipin Garg, M.D.
Pulmonary Disease · Elizabeth, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Garg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Garg
Dr. Vipin Garg is a pulmonary disease specialist in Elizabeth, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Garg performed 11,753 Medicare services across 3,511 unique beneficiaries.
Between the years covered by Open Payments, Dr. Garg received a total of $5,428 from 40 pharmaceutical and/or device companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NJ
$5,428 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,753
Medicare services
Top 1% in NJ for pulmonary disease
3,511
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~588 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
1,843 | $181 | $500 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,488 | $101 | $200 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,200 | $4 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,053 | $77 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
886 | $154 | $250 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
743 | $125 | $160 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
433 | $0 | $3 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
403 | $55 | $150 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
376 | $8 | $50 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
376 | $16 | $50 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
368 | $35 | $150 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
327 | $91 | $120 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
244 | $53 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $109 | $200 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
221 | $43 | $100 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
160 | $91 | $250 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
147 | $49 | $140 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
147 | $52 | $180 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
134 | $16 | $51 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
114 | $146 | $400 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
112 | $30 | $150 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
90 | $99 | $200 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
75 | $78 | $500 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
74 | $47 | $100 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
68 | $33 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
51 | $13 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
51 | $34 | $50 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
46 | $17 | $50 |
| New patient office visit, complex (60-74 min) | 44 | $191 | $400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $46 | $65 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
37 | $156 | $200 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
35 | $24 | $48 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
34 | $62 | $100 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 21 | $20 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
20 | $1 | $30 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
15 | $9 | $60 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
14 | $92 | $350 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
13 | $46 | $200 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
12 | $281 | $350 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $29 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,428
Total received (2018-2024)
Avg $775/year across 7 years
Top 27% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
310
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,415 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,059
2023
$903
2022
$872
2021
$821
2020
$401
2019
$654
2018
$719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$198
GlaxoSmithKline, LLC.
$131
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$125
Itamar Medical Inc
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$113
Avadel CNS Pharmaceuticals, LLC
$78
GENZYME CORPORATION
$63
AstraZeneca Pharmaceuticals LP
$46
Insmed, Inc.
$34
ANI Pharmaceuticals, Inc.
$33
Philips North America LLC
$31
United Therapeutics Corporation
$30
Mallinckrodt Hospital Products Inc.
$16
Harmony Biosciences Llc
$16
HARMONY BIOSCIENCES LLC
$16
PFIZER INC.
$15
Top 3 companies account for 42.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,543
Boehringer Ingelheim Pharmaceuticals, Inc.
$694
AstraZeneca Pharmaceuticals LP
$657
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$477
GENZYME CORPORATION
$271
Abbott Laboratories
$198
Philips Electronics North America Corporation
$172
Itamar Medical Inc
$114
Sunovion Pharmaceuticals Inc.
$108
Gilead Sciences, Inc.
$90
Avadel CNS Pharmaceuticals, LLC
$78
Merck Sharp & Dohme Corporation
$70
ANI Pharmaceuticals, Inc.
$65
Eisai Inc.
$58
United Therapeutics Corporation
$58
Mallinckrodt Hospital Products Inc.
$57
Merck Sharp & Dohme LLC
$57
Harmony Biosciences LLC
$53
Amgen Inc.
$53
Genentech USA, Inc.
$52
JAZZ PHARMACEUTICALS INC.
$43
Bayer HealthCare Pharmaceuticals Inc.
$40
Regeneron Healthcare Solutions, Inc.
$39
Mylan Specialty L.P.
$38
Insmed, Inc.
$34
Philips North America LLC
$31
Novartis Pharmaceuticals Corporation
$30
Strongbridge US INC.
$29
PFIZER INC.
$26
Teva Pharmaceuticals USA, Inc.
$25
Exact Sciences Corporation
$24
Exeltis, USA Inc.
$17
Inogen, Inc.
$17
Circassia Pharmaceuticals Inc
$17
Fisher & Paykel Healthcare Inc
$16
Harmony Biosciences Llc
$16
HARMONY BIOSCIENCES LLC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$14
Xeris Pharmaceuticals, Inc.
$14
Mallinckrodt Enterprises LLC
$14
Top 3 companies account for 53.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AMPLATZER AMULET · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · ArmonAir Digihaler · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · Cologuard Collection Kit · DIFICID · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · FASENRA · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · KEVEYIS · LONHALA MAGNAIR · LUMRYZ · LifeVest · NUCALA · OFEV · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Repatha · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TRUMENBA · TUDORZA PRESSAIR · TYVASO · WAKIX · WatchPATONE · Wellcentive Undiv · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
597
Per 100K population
104.3
County median income
$100,117
Nearest hospital
NEWARK BETH ISRAEL MEDICAL CENTER
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Garg is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Garg experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Garg performed 1,843 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garg receive payments from pharmaceutical companies?
Yes. Dr. Garg received a total of $5,428 from 40 companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garg's costs compare to other pulmonary diseases in Elizabeth?
Dr. Garg's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Elizabeth
Browse pulmonary diseases in Elizabeth ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology